if you email them during the week they are very prompt on emailing back and even giving you their phone number cell that they can be reached at for more clarification, they are very good. But you do have to be willing to give them your information as email or phone number. They aren't sitting there waiting for your call but it is extremely prompt as far as I have experienced.
all of their previous five splits have been 2/1 and at around $80 so that is the reason for the statement if history is an indicator.
I understand the statement 2 nickels for a dime but it does allow for a little appreciation as more demand is available for lower prices, some don't understand the logic of $50 stock at 10 pe is not as good as $100 stock at 8 pe in same business with same outlook they feel the $50 is cheaper. As professional investors we should know the difference but it just aint so in the market.
from the studies I have looked at GILD's hep c drug is by far the best and most effective of all hep c drugs on or in process. It will be the drug of choice in a US market of 336 Billiion (84000 X 4 million Hep C virus infected) then you have the rest of the world. This number needs to be looked at with discounts, and non users but it is a huge potential market for just the US. My opinion is it won't take to 2018 to reach that 8 B mark heck that is only 100,000 patients or 2.5% of the US market, they may do that by 2015. If you have Hep C virus your liver is being destroyed and why would you want to wait until you are on dialysis for treatment and your life expectancy goes down. These are very expensive to insurance companies also so there is a reward for them to approve rapidly and they will go with the most effective.
while the approval is not a surprise to most the amount of earnings this will generate starting next quarter will be, this is the cadillac of HEP C drugs and it will explode beyond the majority consensus IMO and by end of 2014 this company could be well over 110. remind me next year please. but if you sell don't stand on the sidelines long or you will be left behind
the sales from this drug alone will get them to a profitable situation and cover the current outflow of cash within 6 months by all analysts predictions, Then you have other drugs that should be coming on line. You are way off base on this one.
example, in july 12 when GS was in the low90s I bought 3000 shares and I day traded an additional 2000 shares and did until the stock hit 150s on the core position of 3000 shares i made 180k on the day trading 2000 shares I made 250k so in my mind I really made 130k day trading as the rest was from stock appreciation had I held and not traded less margin charges as I did this with house money at 3.15% annual rate but some had no charge as I seldom held overnight.
when I day trade I trade similarly, but only on stocks I own, I use approximately 350k in funds to day trade, and have made $76k in last 8 weeks if I get stuck in a trade and hold it longer than a week to make money I do not count it as day trade profit but core position profit, I never put in stop loss orders except mentally. no use giving the opposition any heads up on where to take it. I may trade the same stock as many as 6 to 8 times a day if circumstances are correct, I would not recommend this to any one for several reasons, 1) very stressful and why I only do it for several months then take a break, 2) as you state mental disposition makes most traders losers 3) not everyone can afford the hit should it come. I have been blessed in the last year and now trading on their money. It has been a good year.
I was not supporting the individual as I don't like his behavior nor do I believe his posts, I only day trade stocks I currently own for in my core position, so PSEC is not currently there, I have been day trading for over a year and have been fortunate that 98% of my trades have been profitable even taking the price inflation of the trade out looking at it as if I had held the stock or traded it. I only do this with 20% of my portfolio and seldom go overnight. penny ones verbal assaults are uncalled for and he/she has to be a very unhappy person with few friends if any. In some ways I feel sorry for the person but mostly disgusted.
first off, the sales will not be that high as they will only get a part of the market depending on how well of a job Par pharma reps do with doctors, but I could not find the revenue participation % either, but to answer the next poster, I stated the $15Million milestone from an article from SA and after research and another poster found that to be false, the company IR denies such milestone agreement, I have no idea where the author got that information and on emailing him have gotten no response.
some analysts are saying by 2018 this will bring in 8B per yr and next yr 1.7B I think that is on low side considering the size of the market and the cure rate and alternatives then you have the rest of the world. This will be mega for GILD and the research and other drug companies they will be able to buy from proceeds.
Olysio is not as effective and doesn't work on all types of Hep C in fact the majority of the type in the USA so they have to test to see if that type so it is only 58% effective vs Sovaldi which is 90% J&J is in trouble with their product, GILD will be a hands down choice of ins and drs. This will be huge for GILD and as earnings come in and script numbers you will properly see this stock price rocket even more.
this is a large pharma company so it will affect it but not like a small cap. but it should keep its upward trend intact. As many have said it was in the cards and not a big surprise, had it gone the other way you would have seen a huge downside, as it is a lot of premium goes out of the puts monday. The stock will continue its upside but surprise if it is up $2. They have given estimates of this company doing 3Billion more in revenues next year. earnings will beat estimates. just not a big pop. but for those of us that day trade besides our core positions this will help make MOnday, I traded this 5 times today and made $1100.00 and expect to make more MOnday because I went into close with some open trading positions. There will also be some buyers who got out just in case of the turn down from FDA as it would have crushed and upside wasn't that big as down.
while a lot was already in the stock price as surety of this passing was very high, it is not over, this will continue to go up in value but will also see PE compression as earnings go up but they will go up more than current analysts are projecting as this drug will be huge, it is approved for many types of current hep c that other drugs are not and is now the DRUG of CHOICE. You will see this close above 75 Monday unless the market crashes. New highs are on the way. just a lot of games in AH and should be ignored.